Lead Product(s) : Anamorelin HCl
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Marketing approval of Adlumiz® (generic name: anamorelin hydrochloride) Tablet 50mg (“Adlumiz”) is mainly based on the results from the ONO-7643-04 and ONO-7643-05 studies conducted in Japan in patients with cancer cachexia.
Brand Name : Adlumiz
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 22, 2021
Lead Product(s) : Anamorelin HCl
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?
Reset All
